Cytokine-induced killer cells carrying recombinant oncolytic adenovirus expressing p21Ras scFv inhibited liver cancer

Background: Oncolytic adenovirus-mediated gene therapy is an emerging strategy for cancer treatment. However, oncolytic adenoviruses are mainly administered locally at tumor site. Intravenous administration of oncolytic adenovirus for cancer gene therapy is a problem that needs to be solved urgently...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Fang, Zhang, Peng-Bo, Feng, Qiang, Pan, Xin-Yan, Song, Shu-Ling, Cui, Jing, Yang, Ju-Lun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040716/
https://www.ncbi.nlm.nih.gov/pubmed/33854636
http://dx.doi.org/10.7150/jca.51434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040716/
https://www.ncbi.nlm.nih.gov/pubmed/33854636
http://dx.doi.org/10.7150/jca.51434

Ejemplares similares